Importantly, whereas AZD-1775 treatment of leukemia cells triggered cyclin B/CDK1 (cdc2) Tyr15 dephosphorylation, it also induced Chk1 activation and Thr14 phosphorylation [128]. The gene discussed is CDK1; the disease is leukemia.